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Abstract 
Title: Anesthetic Considerations for the Use of Acceleromyography for Neuromuscular 
Blockade  
Background: Acceleromyography is a quantitative, objective neuromuscular monitor utilized to 
monitor neuromuscular blockade during the perioperative period. Failure to adequately monitor 
neuromuscular blockade can result in residual paralysis. Although the prevalence of monitoring 
neuromuscular blockade remains low, monitoring neuromuscular blockade after a patient has 
received a neuromuscular blocking agent is a standard of care  
Purpose: The purpose of this independent project is to review the current literature and practice 
recommendations regarding clinical management using acceleromyography neuromuscular 
monitoring in the perioperative setting.   
Process: A comprehensive review of the literature was performed utilizing CINAHL and 
PubMed databases from the University of North Dakota Harley French Library. The findings 
were analyzed to determine significance for this project. 
Results: Motor neuron and muscle cell communication takes place at the neuromuscular 
junction. The post-synaptic junction at the neuromuscular junction is the site where both 
depolarizing and non-depolarizing neuromuscular blocking agents act. Anticholinesterase 
medications antagonize the effects of non-depolarizing neuromuscular blocking agents by 
competitively binding to the post-synaptic receptor at the neuromuscular junction. The 
acceleromyography neuromuscular monitor is an objective, quantitative monitor utilized to 
assess blockade in patients who received neuromuscular blocking medications during surgery. 
Calibrating the acceleromyography monitor is recommended in scientific research however, it is 
still undecided if it is warranted in the clinical setting. Monitoring at the adductor pollices muscle 
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is the most accurate monitoring site. The oribularis oculi muscle site is not recommended when 
using an acceleromyography monitor. The flexor hallucis brevis muscle may be considered as an 
alternative site. The primary advantage of using an acceleromyography monitor over qualitative 
neuromuscular monitors is its ability to provide a train of four ratio. A train of four ratio of 
greater than or equal to 0.9 decreases incidence of residual paralysis.  
Implications: Incidence of residual paralysis may be reduced with the implementation of 
acceleromyography neuromuscular monitoring.  
Keywords: acceleromyography, train of four monitoring, quantitative train of four monitoring, 
residual paralysis, residual neuromuscular blockade 
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Anesthetic Considerations for the Use of Acceleromyography for Neuromuscular Blockade 
 Acceleromyography neuromuscular monitoring was introduced in the late 1980s 
(Claudius & Viby-Mogensen, 2008). It is a quantitative monitor utilized to assess the level of 
neuromuscular blockade in patients who received neuromuscular blocking medications during 
surgery. Monitoring the depth of neuromuscular blockade can also be evaluated with clinical 
tests such as head lift and grip strength.  However, these tests have been found to be subjective, 
unreliable and require patient cooperation (Claudius & Viby-Mogensen, 2008).  
 Prevalence of monitoring using qualitative, subjective nerve stimulators is less than 40% 
(Brull & Kopman, 2017). Prevalence of monitoring using quantitative, objective neuromuscular 
monitoring is even lower at less than 17% (Brull & Kopman, 2017). Accurately monitoring 
neuromuscular blockade can affect the patient’s outcome postoperatively. A case report of a 
young, healthy woman undergoing a parietal craniotomy utilizing a TOF-WATCHTM 
acceleromyography monitor will be discussed. A review of the literature including 
pathophysiology, pharmacology, train of four monitoring, acceleromyography monitor 
calibration, acceleromyography monitoring sites, and residual paralysis will be presented.   
Purpose 
 The purpose of this independent project is to provide anesthesia practitioners with 
evidence-based research regarding the use of acceleromyography neuromuscular monitoring. 
Assessing neuromuscular blockade when a neuromuscular blocking agent is utilized is a standard 
of care for anesthesia practitioners. Therefore, having the ability to know how many receptors 
continue to be occupied by the neuromuscular medication is essential for the provider to be able 
to safely extubate the patient.   
  
6 
ACCELEROMYOGRAPHY 
  
Case Report 
 A 32-year-old, 150 cm, 55 kg, female presented for a left parietal craniotomy for the 
treatment of a meningioma brain tumor. Her medical history included meningioma, latent 
tuberculosis of the lungs, and chronic left sided headaches. Surgical history included a cerebral 
angiogram the day prior to the proposed surgery. She had no history of anesthetic complications. 
Current medication included Isoniazid.  
 The patient was considered an American Society of Anesthesiologists physical status 
level three. Airway evaluation revealed a Mallampati score of 2 with a thyromental distance of 3 
fingerbreadths. Bilateral breath sounds were clear to auscultation. She had a regular rate and 
rhythm, no murmurs, gallops or rubs. Neurologically, she presented with chronic left sided 
headaches. Preoperative vital signs were: blood pressure 127/92 mmHg, heart rate 103/min, 
respirations 20/min, room air oxygen saturation (Sp02) 96%, and temperature 97.6° Fahrenheit.  
 The patient was given midazolam 1 milligram (mg) intravenously (IV) upon arrival to the 
operating room (OR). She was assisted onto the operating room table per OR staff. Standard 
non-invasive monitors were applied simultaneously which included: finger pulse oximetry, five-
lead electrocardiogram (EKG), and a blood pressure cuff. 
 The patient’s vital signs before induction were: 147/93 mmHg, heart rate 103/min, 
respirations 21/min, 99% SpO2, 25 mmHg end-tidal carbon dioxide (ETCO2). Inhalation and 
intravenous induction ensued with oxygen at 10L per minute and sevoflurane end-tidal 
concentrations of 1.25%. Fentanyl 100 micrograms (mcg) IV, lidocaine 40 mg IV, and propofol 
110 mg IV were administered for induction. The ability to ventilate was confirmed with chest 
rise, ETCO2 and mask fogging. Subsequently, rocuronium 30 mg IV was administered. A 7.0 
millimeter cuffed endotracheal tube (ETT) was placed by direct laryngoscopy utilizing a MAC 
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three blade with a grade one Cormack and Lehane view. After intubation, bilateral breath sounds 
were auscultated, ETCO2 monitoring was present, and the ETT was secured at 21 centimeters 
(cm) at the lip. The patient was placed on volume control mode with a respiratory rate of 12/min, 
and a tidal volume of 460 mL. Sevoflurane was turned off, and desflurane was initiated with end-
tidal concentrations of 5% throughout the procedure. Inspired oxygen was titrated to 60% and air 
40% was administered to keep flows at 1 liter (L) per minute. A nasopharyngeal probe was 
inserted for temperature monitoring with temperatures of 36.7° C throughout the procedure. 
After induction, two 18-gauge IV’s were placed in addition to the preexisting 20-gauge IV.  A 
dexmedetomidine infusion was initiated at 0.4mcg/kg/hr intravenously for multimodal amnesia. 
A remifentanil infusion was initiated at 0.15 mcg/kg/min intravenously for multimodal analgesia. 
After several attempts by multiple anesthesia practitioners, a 20-gauge arterial line was 
successfully placed in the left radial artery to monitor precise blood pressures. The patient’s 
blood pressure decreased to 61/33 mmHg with a mean arterial pressure (MAP) of 44 mmHg. A 
phenylephrine 200 mcg bolus was given IV. A phenylephrine drip was started intravenously at 5 
mL/hr to maintain systolic blood pressures greater than 100 mmHg to ensure adequate perfusion 
to her brain. For nausea prophylaxis, ondansetron 4 mg IV and dexamethasone 10 mg IV were 
administered. Acceleromyography, to monitor neuromuscular blockade, was applied without 
calibration with a standard current of 50 mA to the right thumb and electrodes on the ulnar nerve 
to elicit contraction of the adductor pollices muscle. The train of four (TOF), which was used to 
assess neuromuscular blockade showed one out of four (1/4) twitches, thirty-one minutes after 
the last dose of rocuronium. Two grams (g) of cefazolin was administered IV for a preoperative 
antibiotic.  
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The patient was positioned, per OR staff, supine with her arms tucked at her sides 
ensuring the ability of the right thumb to freely move. The OR table was turned 180 degrees 
away from the anesthesia provider. A lower Bair Hugger was placed on the patient with a 
temperature setting of 43° C. Levetiracetam 1000 mg was given IV for seizure prophylaxis. The 
dexmedetomidine infusion was decreased to 0.3 mcg/kg/hr due to the medication’s hypotensive 
side effects and the patient’s corresponding hypotension. The patient had 1/4 twitches on the 
acceleromyography monitor forty-five minutes after the last dose of rocuronium. The 
phenylephrine drip was discontinued, twenty-nine minutes after initiation, as the blood pressures 
were 123/80 mmHg with a MAP of 100 mmHg. Fifty-one minutes after the last dose of 
rocuronium, a TOF was checked revealing 2/4 twitches. Rocuronium 10 mg IV was administered 
to maintain a TOF less than 2/4 twitches. Mannitol 30 mg IV was administered over twenty-five 
minutes to decrease intracerebral volume. TOF was again checked thirty-two minutes after the 
last dose of rocuronium, revealing 2/4 twitches. Rocuronium 10 mg IV was administered. 
Ofirmev 1 g IV was administered for multimodal analgesia. Two and a half hours after the case 
began, an arterial blood gas and labs were drawn revealing: Ph 7.38, PCO2 33 mmHg, PO2 157 
mmHg, O2 99%, base excess -6, HCO3 19 mmol/L, HBG 11.6 g/dL, HCT 34 g/dL, glucose 162 
mg/dL, NA 138 mmol/L, K 4.3 mmol/L, Ionized Ca 1.03 mmol/L. Calcium gluconate 1 g IV was 
ordered and administered to increase the patient’s intravascular calcium as her Ionized Calcium 
was 1.03 mmol/L.  Albumin 5% (250mL) IV was administered for fluid replacement. TOF was 
again checked thirty-eight minutes after the last dose of rocuronium, revealing 2/4 twitches. 
Rocuronium 10 mg IV was administered. A TOF was again checked thirty-eight minutes after 
the last dose of rocuronium, revealing 2/4 twitches. An additional dose of rocuronium 10 mg IV 
was administered to maintain paralysis. At the same time, albumin 5% IV was given for volume 
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replacement. Twenty-eight minutes after the last dose of rocuronium, a TOF was checked 
revealing 1/4 twitches. The surgeon began closing the wound; paralysis was no longer warranted, 
and the rocuronium boluses were discontinued. A TOF was checked 40 minutes after the last 
dose of rocuronium, revealing 4/4 twitches. Ondansetron 4 mg IV and cefazolin 2 g IV were 
administered as it had been four hours since they were administered. Four and a half hours into 
the case a second set of arterial blood gases and labs were drawn revealing: Ph 7.38, PCO2 33 
mmHg, PO2 167 mmHg, O2 99%, base excess -6, HBG 9.9 g/dL, HCT 29 g/dL, glucose 175 
mg/dL, Na 139 mmol/L, K 4.4 mmol/L, Ionized Ca 1.33 mmol/L. The dexmedetomidine 
infusion was discontinued. The phenylephrine infusion was restarted at 5 mL/hr IV for seven 
minutes due to systolic blood pressures being less than 100 mmHg. The remifentanil infusion 
was decreased to 0.05 mcg/kg/min. Glycopyrolate 0.2 mg IV and neostigmine 2.5 mg IV were 
administered to antagonize any remaining neuromuscular blockade. Lidocaine 50 mg IV was 
administered to decrease coughing. The patient met extubation criteria as evidenced by regular 
spontaneous respirations of 8/min, tidal volume consistently greater than 300 mL and bilateral 
equal hand grip strength.  
During the five-hour thirty minute surgical case, the patient received a total of 3,000 mL 
of normal saline, 475 mL lactated ringers and 500 mL 5% albumin. Estimated blood loss was 
850 mL and urine output was 2,635 mL. The patient was discharged home on postoperative day 
thirteen with home care.  
Literature Search 
 A review of the evidence was pursued with an online search using CINAHL, PubMed, 
and the American Association of Nurse Anesthetists (AANA) website. CINAHL and PubMed 
databases were accessed utilizing the University of North Dakota Harley French Library. All 
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journal articles were carefully analyzed and selected to provide evidence regarding the use of 
acceleromyography.  
CINAHL was utilized for its association with nursing health research (Mateo & Foreman, 
2014). Four searches were performed in the CINAHL database. The first search utilized the 
search words “train of four monitoring” with the all text option. This resulted in 7,633 articles. 
The all text option was changed to the abstract option to narrow the results. This resulted in 
forty-six articles, of which five were saved.  
A second search within the CINAHL database was performed with the search words 
“qualitative train of four monitoring” with the all text option selected, which yielded 2,815 
articles. Again, the all text option was changed to the abstract option to narrow the results. This 
resulted in five articles, two of which were duplicates, no articles were saved. 
A third search within the CINAHL database was performed with the search word 
“acceleromyography” with the all text option. This resulted in thirty-nine articles of which two 
new articles were saved with three articles previously found in the first search.  
A fourth search within the CINAHL database was performed with the search words 
“residual neuromuscular blockade” with the all text option selected. This resulted in 238 articles. 
The all text option was changed to the abstract option to narrow the results. This resulted in 
thirty-two articles of which one new article was saved.  
PubMed was utilized for its large amount of research in the biomedical arena (Mateo & 
Foreman, 2014). Three searches were performed. The first search utilized the search words “train 
of four monitoring” in all fields. This resulted in 2,979 articles. To narrow the search, the all 
fields option was changed to title/abstract. This yielded thirty-eight articles of which one new 
article was saved, and one article was a duplicate from prior searches. 
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A second search in the PubMed database was performed with the search words 
“qualitative train of four monitoring” in all fields. This resulted in twenty-nine articles. Five new 
articles were saved, and two were duplicates from prior searches.  
A third search in PubMed database was performed with the search word 
“acceleromyography” in all fields. This resulted in two-hundred and forty articles. In an attempt 
to narrow the search, the all fields option was changed to title/abstract. This yielded the same, 
two-hundred and forty articles. Eight new articles were saved, and seven articles were duplicates. 
In one of the eight saved articles, the reference list provided an additional article to use by 
searching the PubMed database. 
The AANA website was accessed with the search terms “standards of care”. This resulted 
in one new article. 
After searches within the CINAHL and PubMed databases had been completed, a total of 
twenty-four articles were saved and reviewed. A review of the literature will be discussed in 
detail in the following section.  
Review of Literature 
Pathophysiology 
 The neuromuscular junction is the site where the motor neuron and muscle cell 
communication occurs. At the neuromuscular junction, the neuron and muscle fibers are 
separated by the synaptic cleft. When the nerve’s action potential becomes depolarized, an influx 
of calcium ions travels through the voltage-gated calcium channel into the nerve cytoplasm. This 
allows storage vesicles to fuse together with the terminal plasma to release acetylcholine (ACh). 
The ACh molecules move across the synaptic cleft and bind to nicotinic cholinergic receptors on 
the muscle membrane’s motor end-plate. (Butterworth, Mackey, & Wasnick, 2013)  
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 The makeup of the ACh receptors changes in different tissues and at different times in 
development. Each ACh receptor consists of five protein subunits: two α, one β, δ, and ε or γ. 
The γ subunit is substituted instead of the ε when the receptor is fetal or immature. Only two 
identical α subunits can bind to ACh molecule. If both ACh binding sites are occupied, the ion 
channel will open. Conversely, if only one ACh binding site is occupied, the ion channel will not 
open. (Butterworth et al., 2013) 
 The end-plate potential is generated by sodium and calcium flowing through the open 
ACh receptor channel and potassium flowing out. When enough ACh receptor sites are 
occupied, the end-plate potential will depolarize the perijunctional muscle membrane. Voltage-
gated sodium channels within the perijunctional muscle membrane open when a threshold 
voltage is developed across them. The opening of the sodium channels allows for the release of 
calcium from the sarcoplasmic reticulum. The intracellular calcium is what provides muscle 
contraction. (Butterworth et al., 2013) 
 ACh is hydrolyzed into acetate and choline by the enzyme acetylcholinesterase. This 
enzyme is located on the motor end-plate adjacent to the ACh receptors. After unbinding ACh, 
the receptors’ ion channels close, allowing the end-plate to repolarize. Calcium moves back into 
the sarcoplasmic reticulum causing muscle relaxation. (Butterworth et al., 2013) 
Pharmacology  
Neuromuscular blocking drugs are frequently used in the perioperative setting. There are 
two different classes of neuromuscular blocking drugs that can be used; depolarizing or non-
depolarizing. The type of neuromuscular blocker used is based on numerous factors such as 
perception of ease of intubation with an endotracheal tube, laboratory values specifically 
potassium, length and type of surgical procedure, as well as practitioner preference.  
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Depolarizing and non-depolarizing neuromuscular blocking agents (NDMA) provide 
paralysis by acting on the post-synaptic junction at the neuromuscular junction. Depolarizing 
neuromuscular blockers are composed of two ACh molecules whereas NDMA’s are composed 
of one ACh molecule.   
Anticholinesterase medications are used to antagonize the effects of NDMA’s. They 
work by competitively binding to the postsynaptic receptor at the neuromuscular junction (Brull 
& Kopman, 2017; Kopman & Eikermann, 2009). Anticholinesterases slow the breakdown of 
ACh thereby increasing the concentration of acetylcholine at the post-synaptic nicotinic receptor 
on the muscle, thus re-establishing normal function (Brull & Kopman, 2017; Kopman & 
Eikermann, 2009; Nagelhout, 2013). Once the enzyme is inactivated, additional 
anticholinesterase will not increase the availability of ACh.  
Depolarizing neuromuscular blockers are not able to be antagonized with an 
anticholinesterase medication because the depolarizing neuromuscular blocker binds to both 
ACh sites thereby not allowing a site of action for the anticholinesterase medication. 
Depolarizing neuromuscular blockers are reversed by the body’s plasma cholinesterase.  
Train of Four Monitoring 
Dosing of NDMA’s and antagonizing their effects can be decided by evaluating the 
patient condition, surgical procedure type and length, time from the last dose of NDMA, as well 
as using neuromuscular monitors. The American Association of Nurse Anesthetists (2013) states, 
“when neuromuscular blocking agents are administered, monitor neuromuscular response to 
assess depth of blockade and degree of recovery” (p. 1). Although it is a standard of care to 
monitor neuromuscular blockade and recovery, less than 40% of patients are monitored with a 
qualitative monitor and less than 17% with a quantitative monitor (Brull & Kopman, 2017).  
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The gold standard of neuromuscular monitors is mechanomyography, a quantitative, 
objective monitor (Brull & Kopman, 2017; Heir & Hetland, 1999). Mechanomyography is not 
used in clinical practice due to the complexity of its setup (Brull & Kopman, 2017). There are 
several quantitative and qualitative neuromuscular monitors available in clinical practice.  
A qualitative, subjective neuromuscular monitor such as the peripheral nerve stimulator 
(PNS) is used most often in clinical practice (Bhananker et al., 2015; Brull & Kopman, 2017). 
The PNS is classified as a qualitative measure since it relies on the provider’s subjectivity to 
visually and/or tacitly assess the patient’s response to an electrical stimulus. The PNS elicits an 
electrical stimulus to a peripheral nerve corresponding with a muscle contraction. The response 
seen from the contraction of the muscle is referred to as a twitch (Welliver, Murphy, Kopman, & 
Brull, 2015). Many PNS’ can assess a single twitch, TOF count, double burst stimulation, and 
post-tetanic count. The TOF count is the most commonly used function of a qualitative monitor 
(Bhananker et al., 2015; Brull & Kopman, 2017). A TOF of 1 to 2 twitches provides an adequate 
amount of muscle relaxation for most procedures (Nagelhout, 2013). Fade is determined by 
subjectively evaluating the force of the muscle contraction of the 4th twitch compared to that of 
the 1st twitch. The absence of fade occurs when the force of contraction at the 4th and 1st twitch is 
equal. The PNS’ major limitation beyond its subjectivity, is that it does not provide a ratio of 
receptor blockade once the TOF count has reached 4/4.  
Mechanomyography, electromyography, kinemyography, phonomyography, and 
acceleromyography are objective and quantifiable monitors available to assess neuromuscular 
blockade (Claudis & Viby-Mogenson, 2008). These quantifiable monitors detect a TOF count 
and a TOF ratio. The ratio can be calculated once the TOF count reaches 4/4 and provides the 
difference of amplitude between the fourth and first twitch on a neuromuscular monitor (Thilen 
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& Bhananker, 2016). Of the quantitative, objective neuromuscular monitors available, the 
acceleromyography monitor is the most widely used (Claudius & Viby-Mogenson, 2008; Fuchs-
Buder, Nemes, & Schmartz, 2016). A cohort study by Bhananker et al. (2015), found anesthesia 
providers overestimate the TOF count, especially during counts of 1, 2, and 3, utilizing a 
qualitative peripheral nerve stimulator in comparison to the quantitative acceleromyography 
monitor, TOF-WATCH SXTM.   
Acceleromyography can be used to measure the patient’s amount of blockade through 
quantifying the number of twitches via the acceleration of muscle tissue in response to nerve 
stimulation (Brull & Kopman, 2017). Acceleromyography is based on Newton’s second law of 
motion where force equals mass times acceleration (Claudius & Viby-Mogensen, 2008; Welliver 
et al., 2015; Brull & Kopman, 2017).  Brull and Kopman (2017) state: 
A piezoelectric transducer is attached to a muscle, and when the innervating nerve is 
stimulated, the muscle movement is sensed by the transducer; a voltage is generated in the 
piezoelectric crystal, and this electrical signal is analyzed by the acceleromyography 
monitor. (p. 186) 
For example, if the piezoelectric crystal is attached to the thumb (constant mass), the acceleration 
from the contracted adductor pollices muscle is proportionate to the force needed to move the 
thumb.   
Gätke et al. (2002) completed a prospective, randomized and double-blind study 
evaluating the effects of monitoring with an acceleromyography monitor, TOF-Guard Bextel®, 
and intermediate acting NMDA, rocuronium. The use of the acceleromyography monitor did not 
allow for more accurate titration of rocuronium during the intraoperative period. The lack of 
titration ability found by Gätke et al. (2002) may have been due to the length of surgery with a 
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mean of 66.5 minutes and range of 14 to 409 minutes. Since the duration of action of rocuronium 
is thirty to sixty minutes, the surgeries observed by Gätke et al. (2002) may not have required 
additional paralysis. 
Acceleromyography Calibration 
Calibration of the acceleromyography monitor is recommended after administering 
induction agents and prior to administering neuromuscular blocking agents (Schreiber, 2014). 
The purpose of calibration is to adjust a supramaximal intensity current that is specific to each 
patient before receiving a NMDA (Schreiber, Mucha, & Fuchs-Buder, 2011; Colegrave, Billard, 
Motamed, & Bourgain, 2016). Calibration is recommended in scientific research. However, it is 
still undecided if it is warranted in the clinical setting. Calibrating the acceleromyography does 
not provide 100% reliability and may overestimate recovery of neuromuscular blockade by up to 
15% (Schreiber, 2014).  
Schreiber et al. (2011) found at a TOF greater than or equal to 1.0; the non-calibrated 
TOF-WATCH SXTM acceleromyography monitor is as reliable as a calibrated TOF-WATCH 
SXTM acceleromyography monitor to exclude residual neuromuscular blockade. Eliminating 
calibrating prior to the administration of NMDA’s decreases a step during the busy phase of 
induction. The TOF-ScanTM acceleromyography monitor bypasses the need for calibration 
compared to its counterpart TOF-WATCH SXTM (Colegrave et al., 2016). Colegrave et al. 
(2016) found no significant difference during the onset of neuromuscular blockade but 
significant differences during recovery of moderate and deep neuromuscular blockade between 
the TOF-ScanTM and the TOF-WATCH SXTM. Regardless of the differences during recovery of 
the blockade, the TOF-ScanTM is “an acceptable clinical alternative to detect residual paralysis 
before recovery in routine practice” (Colegrave et al., 2016, p.227). 
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Acceleromyography Monitoring Sites 
The effect of NMDA’s are muscle dependent. Stimulating the ulnar nerve at the adductor 
pollices muscle on the arm is the most common mode of intraoperative monitoring in the United 
States (Thilen et al., 2012). Other options, if the hand and arm are inaccessible, are to stimulate 
the facial nerve or the tibial nerve (Heier & Hetland, 1999; Gätke et al., 2002; Larsen et al., 
2002; Thilen et al., 2012).  
A study performed by Capron, Fortier, Racine, & Donati (2006) examined the application 
of electrodes over the ulnar nerve at the wrist versus electrodes on both sides of the hand over the 
adductor pollices muscle with acceleromyography in comparison to the gold standard 
mechanomyography at the adductor pollicis muscle. Capron et al. (2006) found the best 
correlation between acceleromyography and mechanomyography is to have the electrodes placed 
on the hand rather than the wrist.  
Typically, the orbicularis oculi muscle site is used as an alternative for qualitative 
monitoring. This monitoring location is especially useful if arms are tucked due to the nature of 
the surgical procedure. The orbicularis oculi muscle has been shown to correlate more closely 
with diaphragm paralysis than the adductor pollices muscle (Gätke et al., 2002). Therefore, 
monitoring at the orbicularis oculi muscle may be more prudent during the onset of 
neuromuscular blockade. The adductor pollices is more sensitive to NDMA’s than the 
diaphragm, therefore, monitoring at the adductor pollices during recovery of neuromuscular 
blockade may prove to be optimal as the diaphragm has already recovered (Aflfille, Merritt, 
Chamberline, & Eikermann, 2009). Anticholinesterase medications guidelines to antagonize 
NDMA’s are based on assessing the degree of neuromuscular blockade only at the adductor 
pollices muscle (Thilen et al., 2012).   
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A study performed by Gätke et al. (2002) identified correct placement of the electrodes 
for monitoring with acceleromyography is lateral to the eye or along the zygomatic arch. The 
acceleration transducer is placed in the middle of the eyebrow to elicit the greatest response of 
the orbicularis muscle. However, the corrugator supercilii may also be elicited (Gätke et al., 
2002).  
Larsen et al. (2002) found the maximum first response of TOF may be nearly 0% at the 
orbicularis oculi. Meanwhile the maximum first response of TOF at the adductor pollices is 
between 0% and 100% during the onset of neuromuscular blockade. Recovery of neuromuscular 
blockade also varied with a TOF ratio of 1.0 at the orbicularis oculi muscle and 0.20-0.40 at the 
adductor pollices (Larsen et al., 2002). Monitoring one nerve and muscle in the face has been 
shown to be challenging due to the vast amount of nerves and muscles located there (Gätke et al., 
2002; Larsen et al., 2002; Thilen et al., 2012). Monitoring the orbicularis oculi muscle with 
acceleromyography requires increased stimulation to elicit the orbicularis oculi response, 
therefore, increasing the likelihood of eliciting responses from other facial muscles (Gätke et al., 
2002; Larsen et al., 2002). Patients are also at increased risk for residual paralysis monitoring at 
the eye muscles than at the adductor pollices (Thilen et al., 2012).  
Monitoring at the tibial nerve at the ankle joint to elicit the flexor hallucis brevis muscle 
may be considered as an alternative site with the use of acceleromyography (Heier & Hetland, 
1999). A study performed by Heier & Hetland (1999) examined the effectiveness of monitoring 
acceleromyography at the tibial nerve on the ankle joint versus the gold standard of monitoring 
with mechanomyoraphy at the ulnar nerve. Monitoring at the tibial nerve at the ankle joint with 
the acceleromyography is consistent with mechanomyography at the ulnar nerve during the 
period of 0/4 TOF (Heir & Hetland, 1999). The adductor pollices continues to be the 
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recommended site of action to monitor with acceleromyography during induction, duration of 
action, and recovery of neuromuscular blockade (Heier & Hetland, 1999).  
Residual Paralysis  
Incomplete recovery of neuromuscular blockade (residual paralysis) after anesthesia is a 
serious event. Several studies have attributed residual paralysis with adverse events in the 
postoperative period including inspiratory obstruction, hypoxemia-related increase in ventilation, 
postoperative critical respiratory events, intraoperative awareness, and unpleasant symptoms of 
muscle weakness (Fuchs-Buder, Nemes, & Schmartz, 2016; Kopman & Eikermann, 2009; Sauer 
et al., 2011). Residual paralysis may be in part due to dosing and timing of NDMA’s and 
anticholinesterase medications, type of monitor used, and/or clinical assessment.  
Specific anticholinesterase medication dosing recommendations are based on quantitative 
or qualitative neuromuscular monitors (Bhananker et al., 2015). Therefore, this may lead to 
inaccuracy of recommended dosage depending on which anticholinesterase medication was 
administered and what type of monitor was used.  One anticholinesterase medication, 
neostigmine, has dosage guidelines based upon a qualitative TOF monitor (Bhananker et al., 
2015). Kopman and Eikermann (2009) outline guidelines for neostigmine administration with a 
quantitative neuromuscular monitor such as an accelermyograph are: with a TOF count with no 
response the provider should delay administering anticholinesterase until a TOF count of 2 has 
been obtained; with a TOF ratio < 0.4 or TOF count of 2-3 the provider can give neostigmine 
dose 0.02 – 0.05 mg/kg; with a TOF ratio 0.4 – 0.9 a neostigmine dose of 0.015 – 0.025 mg/kg; 
with a TOF ratio > 0.9 the provider does not need to use anticholinesterase to antagonize the 
NDMA previously given.   
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A TOF ratio of less than 0.9 using the ulnar nerve to assess the adductor pollices muscle 
utilizing a quantitative neuromuscular monitor allows for increased incidence of residual 
neuromuscular blockade (Brull & Kopman, 2017; Fuchs-Buder et al., 2016; Murphy et al., 2013; 
Thilen et al., 2012). A TOF ratio greater than 0.4 does not allow providers to accurately assess 
for the presence of fade (Welliver et al., 2015). Thus, if the patient does not have fade, then the 
patient may still be at risk for residual blockade. A TOF count of 4/4 does not eliminate residual 
neuromuscular blockade; in fact, up to 75% of neuromuscular receptors may still be blocked. 
There is evidence of residual paralysis in up to 64% of cases when utilizing qualitative 
monitoring methods (Thilen et al., 2012).  
Quantitative train of four monitoring is the best way to detect residual neuromuscular 
blockade (Gätke et al., 2002). Furthermore, “the acceleromyographic TOF ratio, even in the 
uncalibrated mode, remains the most accurate test to reliably detect residual paralysis” (Capron 
et al., 2006, p. 1582).  
Discussion 
 The patient in this case review was undergoing a parietal craniotomy. Per surgeon 
request, she was pharmacology paralyzed for the duration of the surgical procedure. The patient 
was paralyzed with a TOF of 2/4 twitches or less. She underwent general anesthesia the day 
before without a history of difficult intubation or anesthetic complications. 
After induction and prior to neuromuscular blockade, attempts were made to apply an 
acceleromyography monitor to the right thumb with electrodes on the ulnar nerve. Due to 
challenges with the acceleromyography such as the ability to turn on or calibrate, placing the 
acceleromyography monitor was aborted until after intubation. Calibration is not a necessary step 
in clinical practice according to the literature.   
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The patient was intubated with an intermediate acting NMDA, rocuronium. The 
acceleromyography monitor was switched for another monitor and again applied to the right 
thumb with electrodes on the ulnar nerve without calibration. The piezoelectric transducer was 
taped to the patient’s thumb, and the thumb was allowed to move freely. This is congruent with 
the evidence that if the patient has a thumb that is allowed to move freely, this is the best place to 
monitor neuromuscular blockade.  
After the initial intubating dose of rocuronium 30 mg IV, it took the patient fifty-one 
minutes to reach a TOF of 2/4 twitches. Subsequently, frequent TOF monitoring was performed 
throughout the surgical procedure. Rocuronium was re-dosed at 10 mg increments when the 
patient’s train of four reached 2/4 twitches. On average, it took the patient 36 minutes to reach a 
2/4 TOF after each 10 mg IV bolus of rocuronium. With the use of acceleromyography in this 
patient, it was predictable that she would require an addition bolus of paralytic around 36 
minutes from the prior dose.  
During emergence, the patient received glycopyrrolate 0.2 mg IV and neostigmine 2.5 
mg IV. The patient had a TOF count of 4/4 over an hour prior to receiving an anticholinesterase 
medication, therefore a TOF ratio was not performed. The acceleromyography monitor is 
superior over peripheral nerve stimulators as it provides the practitioner a TOF ratio. The TOF 
ratio can help guide the practitioner as to appropriate anticholinesterase dosages. Twelve minutes 
after glycopyrrolate and neostigmine were administered, the patient received lidocaine 50 mg to 
attenuate the coughing reflex and minimize any increases in intracranial pressures. The patient 
was subsequently extubated without signs of residual paralysis.  
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Conclusion 
Acceleromyography has been shown in the literature to be a useful, qualitative monitor to 
help aid the anesthesia provider in guiding neuromuscular blockade at induction, maintenance, 
and recovery. However, there is a gap in the literature regarding how frequently to monitor 
neuromuscular blockade to provide a moderate block with the use of an acceleromyography 
monitor.  
Further research is needed regarding the necessity of calibrating the acceleromyography 
in clinical practice. An alternative acceleromyography monitor that does not require calibration 
is the TOF-ScanTM.  
Appropriate choice and dosage of NDMA’s may be guided by using the 
acceleromyography monitor. NDMA’s and anticholinesterase inhibitors guidelines should 
include monitoring site when discussing antagonizing the effects of NDMA’s. Monitoring the 
facial nerve at the eye muscles may be an acceptable alternative for qualitative monitoring, 
however, research has found limitations with the use of acceleromyography for monitoring the 
facial nerve (Gätke et al., 2002; Larsen et al., 2002; Thilen et al., 2012).  This is in part due to not 
being able to differentiate specific eye muscles that are elicited by the pizo electric stimulus. The 
preferred site of neuromuscular blockade monitoring is at the adductor pollices muscle. 
The acceleromyography monitor is one tool that can be used to aid the anesthesia 
provider in making an appropriate judgment for tracheal extubation to reduce the incidence of 
residual paralysis. The acceleromyography monitor provides the practitioner with a TOF ratio in 
addition to a TOF count that qualitative monitors provide. A TOF ratio of 0.9 or greater has been 
shown to decrease residual neuromuscular blockade. Therefore, tracheal extubation should not 
occur until a TOF ratio of 0.9 has been achieved. 
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